These symptoms are generally most pronounced when treatment is initiated and tend to decrease in intensity with continued use of the medication
Custom Dosing for Nuanced Weight Loss Many experts know that BMI is an imperfect measurement, and these cut-offs leave out many people whose health can still benefit from weight loss
GLP-1 receptor agonists slow gastric emptying, which has been hypothesized to affect pancreatic function, though this connection remains speculative and lacks supporting clinical evidence
If you experience persistent digestive issues, your PlexusDx provider can help troubleshoot or adjust your approach without stopping treatment
Early improvements in bloating are frequently reported
More potent than its predecessors, retatrutide activates three receptorsGLP-1, GIP, and glucagonas opposed to only one (as is the case with semaglutide) or two (like tirzepatide)